In those over 65, heart failure is the most common reason for hospitalization. Clarification of the cause of the disease is essential to direct patients to targeted therapy. Patients with cardiac ATTR amyloidosis are an important HFpEF subgroup for whom there is a specific therapeutic option that has been shown to improve prognosis.
This content is machine-translated. Please contact us if you need professional translation services.
Publikation
- HAUSARZT PRAXIS
